Abstract:Background Metabolic syndrome (MetS), characterized by obesity, hyperglycemia, and abnormal blood lipid levels, is the pathological basis of many cardiovascular diseases. Gualou-Xiebai-Banxia-Tang decoction (GT) was first described in the Synopsis of the Golden Chamber, the earliest traditional Chinese medicine (TCM) monograph on diagnosis and treatment of miscellaneous diseases in China. According to TCM precepts, based on its ability to activate yang to release stagnation, activate qi to reduce depression, remove phlegm, and broaden the chest, GT has been used for more than 2,000 years to treat cardiovascular ailments. However, the molecular bases of its therapeutic mechanisms remain unclear. Purpose The aim of this study was to identify lipid- and glucose-related hepatic genes differentially regulated by GT, and to assess GT impact on gut microbiota composition, in mice with high-fat diet (HFD)-induced MetS. Study design and methods ApoE − / − mice were fed with an HFD for 24 weeks, with or without concurrent GT supplementation, to induce MetS. At the study's end, body weight, visceral fat weight, blood lipid levels, and insulin sensitivity were measured, and histopathological staining was used to evaluate hepatosteatosis and intestinal barrier integrity. Liver transcriptomics was used for analysis of differentially expressed genes in liver and prediction of relevant regulatory pathways. Hepatic lipid/glucose metabolism-related genes and proteins were detected by RT-qPCR and western blotting. Gut microbial composition was determined by 16S rRNA gene sequencing. Results GT administration reduced MetS-related liver steatosis and weight gain, promoted insulin sensitivity and lipid metabolism, and beneficially modulated gut microbiota composition by decreasing the relative abundance of g_Lachnospiraceae_NK4A136_group and increasing the relative abundance of g_Alistipes . Liver transcriptomics revealed that GT regulated the expression of genes related to lipid and glucose metabolism ( Pparγ, Igf1, Gpnmb , and Trem2 ) and of genes encoding chemokines/chemokine receptors (e.g. Cxcl9 and Cx3cr1 ). Significant, positive correlations were found for Ccr2, Ccl4, Ccr1 , and Cx3cr1 and the g_Lachnospiraceae_NK4A136_group , and between Cxcl9, Ccr2, Ccl4 , and Cx3cr1 and g_Desulfovibrio . GT treatment downregulated the protein expressions of SCD1 and CX3CR1 and upregulated the expression of PCK1 protein. Conclusion GT supplementation alleviates HFD-induced MetS in mice by improving hepatic lipid and glucose metabolism. The anti-metabolic syndrome effects of GT may be related to the regulation of the gut-liver axis.

Comparative analysis of fecal metabolite profiles in HFD-induced obese mice after oral administration of huangjinya green tea extract

Green Tea Catechin Epigallocatechin Gallate Alleviates High‐fat Diet‐induced Obesity in Mice by Regulating the Gut–brain Axis

Huangjinya Black Tea Alleviates Obesity and Insulin Resistance Via Modulating Fecal Metabolome in High-Fat Diet-Fed Mice.

Matcha Green Tea Targets the Gut–liver Axis to Alleviate Obesity and Metabolic Disorders Induced by a High-Fat Diet

Huangshan Maofeng Green Tea Extracts Prevent Obesity-Associated Metabolic Disorders by Maintaining Homeostasis of Gut Microbiota and Hepatic Lipid Classes in Leptin Receptor Knockout Rats

The effect of green tea polyphenols on gut microbial diversity and fat deposition in C57BL/6J HFA mice.

Effects Of Catechin Enriched Green Tea On Body Composition

Effects of (−)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet

Anti-obesity and Hypolipidemic Effects of "jinhua Xiangyuan" Tea Infusion in High-Fat Diet-Induced Obese Rats

Stabilization of hypoxia-inducible factor 1α and regulation of specific gut microbes by EGCG contribute to the alleviation of ileal barrier disorder and obesity

Metagenomics Analysis of Gut Microbiota in a High Fat Diet-Induced Obesity Mouse Model Fed with (-)-Epigallocatechin 3-O-(3-O-Methyl) Gallate (EGCG3″Me)

Compound green tea (CGT) regulates lipid metabolism in high-fat diet induced mice

Effect of tea catechins on gut microbiota in high fat diet-induced obese mice

The Role of Green Tea on the Regulation of Gut Microbes and Prevention of High-Fat Diet-Induced Metabolic Syndrome in Mice.

Yellow leaf green tea modulates the AMPK/ACC/SREBP1c signaling pathway and gut microbiota in high-fat diet-induced mice to alleviate obesity

Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate Metabolic Syndrome in HFD-fed mice

Preventive Consumption of Green Tea Modifies the Gut Microbiota and Provides Persistent Protection from High-Fat Diet-Induced Obesity

The Modulatory Effect of Infusions of Green Tea, Oolong Tea, and Black Tea on Gut Microbiota in High-Fat-induced Obese Mice.

Green Tea Polyphenols Modulate Colonic Microbiota Diversity and Lipid Metabolism in High-Fat Diet Treated HFA Mice

The Novel Intervention Effect of Cold Green Tea Beverage on High-Fat Diet Induced Obesity in Mice

Comparative Study of the Anti-Obesity and Gut Microbiota Modulation Effects of Green Tea Phenolics and Their Oxidation Products in High-Fat-induced Obese Mice.